We match any Advertised Price
PRICE MATCH GUARANTEED
*T&Cs Apply, Australian Suppliers Only

  • ResMed AirCurve 11 ASV device shown from the front, featuring a colour touchscreen displaying therapy options, a black and white housing, and the ResMed logo, on a white background.
  • Rear view of the ResMed AirCurve 11 ASV device showing the air inlet port, power connector, and data port on a white background.
  • ResMed AirCurve 11 ASV device alongside a full-face CPAP mask with headgear and tubing connected, with a smartphone displaying the myAir app, on a white background.
  • ResMed AirCurve 11 ASV device placed on top of a packed travel suitcase, representing portability for use while travelling.
  • Resmed Aircurve 11 Bag on whie background.
  • ResMed AirCurve 11 ASV device shown from the front, featuring a colour touchscreen displaying therapy options, a black and white housing, and the ResMed logo, on a white background.
  • Rear view of the ResMed AirCurve 11 ASV device showing the air inlet port, power connector, and data port on a white background.
  • ResMed AirCurve 11 ASV device alongside a full-face CPAP mask with headgear and tubing connected, with a smartphone displaying the myAir app, on a white background.
  • ResMed AirCurve 11 ASV device placed on top of a packed travel suitcase, representing portability for use while travelling.
  • Resmed Aircurve 11 Bag on whie background.

Resmed AirCurve 11 ASV

Perth CPAP
Contact us today
Resmed AirCurve 11 ASV

Your Details

Fill out you details and prefered contact method and we will be in touch to answer any questions you may have and sort out your plan.

Call back on number provided    Email    Either option

Looking to Purchase?

 

 

The AirCurve 11 ASV* is an adaptive servo-ventilation device for use in patients who have been prescribed ASV therapy by a qualified healthcare professional for central sleep apnea, complex sleep apnea, or periodic breathing.

The device includes integrated connectivity, compatibility with the myAir app, over-the-air software updates, a touchscreen interface, and comfort features. Therapy settings are configured by a healthcare professional to support individual patient needs.

ALWAYS READ THE LABEL AND FOLLOW THE INSTRUCTIONS FOR USE. You should speak to your doctor about your symptoms and whether a CPAP device is suitable for you.

*ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.

 

Key Features: 

  • Adaptive servo-ventilation (ASV) therapy for patients as prescribed by a healthcare professional
  • Automatically adjusts pressure support in response to breathing patterns
  • Digital support tools, including myAir™, Care Check-In, Personal Therapy Assistant and Test Drive^
  • Touchscreen interface designed for simple and intuitive navigation
  • Built-in wireless connectivity for therapy data sharing and support
  • Compatible with the myAir app for therapy insights and guidance

When used with compatible Resmed CPAP masks and accessories, AirCurve 11 ASV provides a connected therapy experience built to maximise comfort.

^Some features are available via the myAir app and with Air11™ devices only.

 

What is included:

The AirCurve 11 ASV system includes the following:

  • AirCurve 11 ASV bilevel device
  • HumidAir™ 11 tub cleanable
  • ClimateLineAir™ 11 heated tubing
  • 90W AC Power Supply Unit
  • Travel bag

 

Additional Features: 

Resmed AirCurve 11 includes access to myAir, the online support program and app that uses the therapy data from your machine to let you know how you slept the night before. It can even provide you with tailored coaching tips, encouragement and support.

 

Contraindications:

Positive airway pressure therapy may be contraindicated in some patients with the following pre-existing conditions:

  • severe bullous lung disease
  • pneumothorax or pneumomediastinum
  • pathologically low blood pressure, particularly if associated with intravascular volume depletion
  • dehydration
  • cerebrospinal fluid leak, recent cranial surgery, or trauma.

ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.

 

User Guide: 

Click Here for User Guide

 

Liquid error (layout/theme line 510): font_url can only be used with a font drop